Rodney A. Prell

Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity

Andrew D. Weinberg, Martin-Muy Rivera, Rodney A. Prell et al. · The Journal of Immunology · 2000 · 385 citations · Full text

A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies

Gabriele Schaefer, Lauric Haber, Lisa Crocker et al. · Cancer Cell · 2011 · 332 citations · Full text

Immunocytochemical Technique, Allergy, Autoimmune Disease +9

Vascular Endothelial Growth Factor Blockade Reduces Intratumoral Regulatory T Cells and Enhances the Efficacy of a GM-CSF–Secreting Cancer Immunotherapy

Betty Li, Alshad S. Lalani, Thomas C. Harding et al. · Clinical Cancer Research · 2006 · 231 citations

Danger and OX40 Receptor Signaling Synergize to Enhance Memory T Cell Survival by Inhibiting Peripheral Deletion

Joseph R. Maxwell, Andrew D. Weinberg, Rodney A. Prell et al. · The Journal of Immunology · 2000 · 219 citations · Full text

T-regulatory Cell, Immunology, Cell Death +20

An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia

Steven R. Leong, Siddharth Sukumaran, Maria Hristopoulos et al. · Blood · 2016 · 151 citations · Full text